thrombin inhibitors (Biochem Pharma/Warner-Lambert)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namethrombin inhibitors (Biochem Pharma/Warner-Lambert)
Drug Alias Namethrombin inhibitors (Shire/Pfizer)Factor Xa inhibitor (Biochem Pharma/Warner-Lambert)BCH-1710P-184
ClassificationSmall molecules
Mechanisms of ActionFactor IIa inhibitorsFactor Xa inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWarner LambertShirePfizer Inc
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A